Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction

Journal of Hospital Infection

Volumn 77, Issue 4, 2011, Pages 338-342

  O'Connell, K ^a   Boo, T W ^a   Keady, D ^a   NiRiain, U ^a   O'Donovan, D ^a   Commane, M ^a   Faherty, C ^a   Cormican, M ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Neonatal intensive care unit; Outbreak; Palivizumab; Polymerase chain reaction; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB;

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; HOSPITAL BED UTILIZATION; HUMAN; INFECTION CONTROL; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS TRANSMISSION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE, NEONATAL; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 79952706067     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.12.012     Document Type: Article

References (27)

1. Hall C.B., Weinberg G.A., Iwane M.K., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009, 360:588.
2. American Academy of Paediatrics Respiratory syncytial virus. Red Book: 2009 Report of the Committee on Infectious Diseases 2009, 560. American Academy of Paediatrics, Elk Grove Village, IL. 28th ed. L.K. Pickering (Ed.).
3. Hall C.B., Douglas R.G. Modes of transmission of respiratory syncytial virus. J Paediatr 1981, 99:100.
4. Hall C.B., Douglas R.G., Schnabel K.C., Geiman J.M. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981, 33:779.
5. Hall C.B., Douglas R.G., Geiman J.M. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975, 132:151.
6. Boyce T.G., Mellen B.G., Mitchel E.F., et al. Rates of hospitalisation for respiratory syncytial virus infection among children in Medicaid. J Paediatr 2000, 137:865-870.
7. Cox R.A., Rao P., Brandon-Cox C. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect 2001, 48:186-192.
8. Kilani R.A. Respiratory syncytial virus outbreak in the NICU: description of eight cases. J Trop Paediatr 2002, 48:118-122.
9. Abadesso C., Almeida H.I., Virella D., Carreiro M.H., Machado M.C. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hosp Infect 2004, 58:38-41.
10. Kurz H., Herbich K., Janata O., Sterniste W., Bauer K. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units. J Hosp Infect 2008, 70:246-252.
11. Thorburn K., Kerr S., Taylor N., van Saene H.K. RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004, 57:194-201.
12. Dizdar E.A., Aydemir C., Erdeve O., et al. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit. J Hosp Infect 2010, 75:292-294.
13. Heerens A.T., Marshall D.D., Bose C.L. Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002, 22:306-307.
14. Thompson W., Shay D., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
15. Halasa N.B., Williams J.V., Wilson G.J., Walsh W.F., Schaffner W., Wright P.F. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Paediatr Infect Dis J 2005, 24:1040-1044.
16. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus in high risk infants. Paediatrics 1998, 102:531-537. The IMpact-RSV Study Group.
17. Wu H., Pfarr D.S., Johnson S., et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Molec Biol 2007, 368:652-665.
18. Kingston S., Murphy B.P. Palivizumab use in preterm neonates. Ir Med J 2010, 103:141-144.
19. Joint Committee on Vaccination and Immunisation (JCVI) Statement on immunisation for respiratory syncytial virus 2010, Department of Health, London.
20. Gunson R.N., Collins T.C., Carman W.F. Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol 2005, 33:341-344.
21. van Elden L.J., van Loon A.M., van der Beek A., et al. Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol 2003, 41:4378-4381.
22. Jonathan N. Diagnostic utility of BINAX NOW RSV - an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Ann Clin Microbiol Antimicrob 2006, 5:13.
23. Casiano-Colón A.E., Hulbert B.B., Mayer T.K., Walsh E.E., Falsey A.R. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 2003, 28:169-174.
24. Henrickson K.J., Hall C.B. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007, 26(11 Suppl). S36-S40.
25. Terashita Gastelum D., Peterson A., Mascola L., Dassey D., Camargo E. Pseudo-outbreak of respiratory syncytial virus infection in a neonatal intensive care unit due to cross-reactivity of surfactant and a rapid immunoassay. Infect Control Hosp Epidemiol 2009, 30:890-892.
26. Liao R.S., Tomalty L.L., Majury A., Zoutman D.E. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays. J Clin Microbiol 2009, 47:527-532.
27. Diagnosis and management of bronchiolitis. Paediatrics 2006, 118:1774-1793.